Stocks
Funds
Screener
Sectors
Watchlists

Latest BlackBarn Capital Partners LP Stock Portfolio

BlackBarn Capital Partners LP Performance:
2025 Q4: 10.62%YTD: 28.58%2024: 3.12%

Performance for 2025 Q4 is 10.62%, and YTD is 28.58%, and 2024 is 3.12%.

About BlackBarn Capital Partners LP and 13F Hedge Fund Stock Holdings

On 2026-02-17, the fund reported it's updated stock portfolio. In the 13F Holdings report, BlackBarn Capital Partners LP reported an equity portfolio of $1.5 Billions as of 31 Dec, 2025.

The top stock holdings of BlackBarn Capital Partners LP are ROIV, DHC, PRVA. The fund has invested 4.4% of it's portfolio in ROIVANT SCIENCES LTD and 2.1% of portfolio in DIVERSIFIED HEALTHCARE TR.

The fund managers got completely rid off NEXTRACKER INC, TEVA PHARMACEUTICAL INDS LTD (TEVA) and MOLINA HEALTHCARE INC (MOH) stocks. They significantly reduced their stock positions in AXCELIS TECHNOLOGIES INC (ACLS), ROIVANT SCIENCES LTD (ROIV) and AMNEAL PHARMACEUTICALS INC (AMRX). BlackBarn Capital Partners LP opened new stock positions in NIQ GLOBAL INTELLIGENCE PLC. The fund showed a lot of confidence in some stocks as they added substantially to COGENT COMMUNICATIONS HLDGS (CCOI), MCGRAW HILL INC and NEXTERA ENERGY INC (NEE).

BlackBarn Capital Partners LP Annual Return Estimates Vs S&P 500

Our best estimate is that BlackBarn Capital Partners LP made a return of 10.62% in the last quarter. In trailing 12 months, it's portfolio return was 28.58%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
niq global intelligence plc29,682,000

New stocks bought by BlackBarn Capital Partners LP

Additions

Ticker% Inc.
cogent communications hldgs73.33
mcgraw hill inc64.56
nextera energy inc24.07
privia health group inc19.22
viking therapeutics inc10.00
diversified healthcare tr6.18

Additions to existing portfolio by BlackBarn Capital Partners LP

Reductions

Ticker% Reduced
axcelis technologies inc-51.71
roivant sciences ltd-29.9
amneal pharmaceuticals inc-28.29
arbutus biopharma corp-7.5

BlackBarn Capital Partners LP reduced stake in above stock

Sold off

Ticker$ Sold
teva pharmaceutical inds ltd-20,200,000
fb bancorp inc-7,508,890
nextracker inc-25,896,500
bv finl inc-4,698,040
molina healthcare inc-18,179,200

BlackBarn Capital Partners LP got rid off the above stocks

Sector Distribution

BlackBarn Capital Partners LP has about 52.3% of it's holdings in Healthcare sector.

Sector%
Healthcare52.3
Others18.9
Real Estate11.4
Utilities9.6
Communication Services5
Technology2.8

Market Cap. Distribution

BlackBarn Capital Partners LP has about 33.6% of it's portfolio invested in the large-cap and mega-cap stocks.

Category%
LARGE-CAP33.6
MID-CAP27.9
SMALL-CAP19.6
UNALLOCATED18.9

Stocks belong to which Index?

About 57% of the stocks held by BlackBarn Capital Partners LP either belong to S&P 500 or RUSSELL 2000 index.

Index%
RUSSELL 200047.4
Others42.9
S&P 5009.6
Top 5 Winners (%)%
ROIV
roivant sciences ltd
36.9 %
VKTX
viking therapeutics inc
31.8 %
mcgraw hill inc
23.8 %
AMRX
amneal pharmaceuticals inc
22.2 %
DHC
diversified healthcare tr
9.7 %
Top 5 Winners ($)$
ROIV
roivant sciences ltd
24.6 M
AMRX
amneal pharmaceuticals inc
4.9 M
VKTX
viking therapeutics inc
4.7 M
mcgraw hill inc
4.4 M
DHC
diversified healthcare tr
2.8 M
Top 5 Losers (%)%
CCOI
cogent communications hldgs
-38.0 %
ACLS
axcelis technologies inc
-13.1 %
PRVA
privia health group inc
-4.4 %
Top 5 Losers ($)$
CCOI
cogent communications hldgs
-8.6 M
ACLS
axcelis technologies inc
-2.6 M
PRVA
privia health group inc
-1.4 M

BlackBarn Capital Partners LP Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of BlackBarn Capital Partners LP

BlackBarn Capital Partners LP has 11 stocks in it's portfolio. CCOI proved to be the most loss making stock for the portfolio. ROIV was the most profitable stock for BlackBarn Capital Partners LP last quarter.

Last Reported on: 17 Feb, 2026
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions